Thyroid Disease CARE Act of 2024

The Thyroid Disease CARE Act of 2024 directs the U.S. Department of Health and Human Services (HHS) to conduct research on thyroid disease, with a focus on identifying and addressing health disparities affecting populations such as racial and ethnic minorities, women, and those with varying insurance coverage or geographic locations. It requires HHS to analyze data from Medicaid, Medicare, and other health programs to study gaps in diagnosis, treatment, and outcomes - particularly for thyroid cancer and persistent symptoms - and develop recommendations for improved care. The bill authorizes $30 million annually for research (2025-2029) and $3 million annually for a public awareness campaign to educate patients and healthcare providers about thyroid disease symptoms, treatment options, and early detection, especially during pregnancy. This legislation aims to enhance evidence-based care through research and outreach without altering existing patient benefits or insurance requirements.